Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 16.106\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCN(CC)c1nc(-c2ccccc2)ncc1S(=O)(=O)c1ccc(C)cc1
b.) Cc1ccc(-c2ccc(=O)n(Cc3cc(C)ccc3C)n2)cc1
c.) O=C(/C=C/Nc1cccc(O)c1)c1ccccc1
d.) CN(C)C(=O)CSc1nnc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)n1C
e.) Cc1ccc(C(=O)N/C(=C\c2ccc(Cl)cc2)C(=O)NCCCN2CCOCC2)cc1
Answer: b. Cc1ccc(-c2ccc(=O)n(Cc3cc(C)ccc3C)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(=O)n(Cc3cc(C)ccc3C)n2)cc1
Cc1ccc(-c2ccc(=O)n(Cc3cc(C)ccc3C)n2)cc1
2-[(2,5-dimethylphenyl)methyl]-6-(4-methylphenyl)pyridazin-3-one